US Unemployment Looms As A Threat To Pharma, But More Impact In 2021

Sweeping job losses in the US have left people uninsured or transitioning from private insurance to Medicaid, which will impact how drugs are reimbursed. Changing payer mix will have an effect on company revenues.

unemployment rate people protesting crowd illustration many people looking for a job
Changing payer mix will have an impact on biopharma bottom lines

More from Drug Pricing

More from Scrip